Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement

被引:58
|
作者
Bulfamante, Gaetano Pietro [1 ,2 ]
Perrucci, Gianluca Lorenzo [3 ]
Falleni, Monica [1 ,2 ]
Sommariva, Elena [3 ]
Tosi, Delfina [1 ]
Martinelli, Carla [1 ]
Songia, Paola [4 ]
Poggio, Paolo [4 ]
Carugo, Stefano [5 ]
Pompilio, Giulio [3 ,6 ]
机构
[1] Univ Milan, Dipartimento Sci Salute, Unita Anat Patol, I-20142 Milan, Italy
[2] ASST Santi Paolo & Carlo, Struttura Complessa Anat Patol & Genet Med, I-20142 Milan, Italy
[3] IRCCS, Ctr Cardiol Monzino, Unita Biol Vasc & Med Rigenerat, I-20138 Milan, Italy
[4] IRCCS, Ctr Cardiol Monzino, Unita Studio Patol Aortiche Valvolari & Coronar, I-20138 Milan, Italy
[5] Univ Milan, Dipartimento Sci Salute, Unita Cardiol, I-20142 Milan, Italy
[6] Univ Milan, Dipartimento Sci Clini & Comunita, I-20122 Milan, Italy
关键词
COVID-19; SARS-CoV-2; heart; cardiomyocytes; INFECTION; ACE2;
D O I
10.3390/biomedicines8120626
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aims: A considerable proportion of patients affected by coronavirus respiratory disease (COVID-19) develop cardiac injury. The viral impact in cardiomyocytes deserves, however, further investigations, especially in asymptomatic patients. Methods: We investigated for SARS-CoV-2 presence and activity in heart tissues of six consecutive COVID-19 patients deceased from respiratory failure showing no signs of cardiac involvement and with no history of heart disease. Cardiac autopsy samples were collected within 2 h after death, and then analysed by digital PCR, Western blot, immunohistochemistry, immunofluorescence, RNAScope, and transmission electron microscopy assays. Results: The presence of SARS-CoV-2 into cardiomyocytes was invariably detected in all assays. A variable pattern of cardiomyocyte injury was observed, spanning from absence of cell death and subcellular alterations hallmarks, to intracellular oedema and sarcomere ruptures. In addition, we found active viral transcription in cardiomyocytes, by detecting both sense and antisense SARS-CoV-2 spike RNA. Conclusions: In this autopsy analysis of patients with no clinical signs of cardiac involvement, the presence of SARS-CoV-2 in cardiomyocytes has been detected, determining variable patterns of intracellular damage. These findings suggest the need for cardiologic surveillance in surviving COVID-19 patients not displaying a cardiac phenotype.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [41] Clinical Outcomes of Children With COVID-19 by SARS-CoV-2 Strain
    Klingensmith, Lauren M.
    Goel, Swati
    Kampalath, Vinay N.
    Cohn, Keri A.
    PEDIATRIC EMERGENCY CARE, 2024, 40 (03) : 243 - 248
  • [42] Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19
    Li, Yang
    Lu, Si-Ming
    Wang, Jia-Long
    Yao, Hang-Ping
    Liang, Li Guo
    HELIYON, 2024, 10 (12)
  • [43] Clinical Manifestation and the Risk of Exposure to SARS-CoV-2 (COVID-19)
    Aleebrahim-Dehkordi, Elahe
    Reyhanian, Ali
    Hasanpour-Dehkordi, Ali
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2020, 11 (01)
  • [44] Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19
    Fathizadeh, Hadis
    Taghizadeh, Sepehr
    Safari, Rohollah
    Khiabani, Saeid Shabestari
    Babak, Bayaz
    Hamzavi, Fatemeh
    Ganbarov, Khudaverdi
    Esposito, Silvano
    Zeinalzadeh, Elham
    Dao, Sounkalo
    Kose, Sukran
    Kafil, Hossein Samadi
    MICROBIAL PATHOGENESIS, 2020, 149
  • [45] SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals
    Smith, Dallas J.
    Lambrou, Anastasia
    Patel, Pragna
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (51): : 1357 - 1364
  • [46] SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
    Johansson, Michael A.
    Quandelacy, Talia M.
    Kada, Sarah
    Prasad, Pragati Venkata
    Steele, Molly
    Brooks, John T.
    Slayton, Rachel B.
    Biggerstaff, Matthew
    Butler, Jay C.
    JAMA NETWORK OPEN, 2021, 4 (01)
  • [47] Lack of evidence of viability and infectivity of SARS-CoV-2 in the fecal specimens of COVID-19 patients
    Joshi, Madhuri
    Mohandas, Sreelekshmy
    Prasad, Sharda
    Shinde, Manohar
    Chavan, Nutan
    Yadav, Pragya D.
    Lavania, Mallika
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [48] Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients
    De Michele, Manuela
    d'Amati, Giulia
    Leopizzi, Martina
    Iacobucci, Marta
    Berto, Irene
    Lorenzano, Svetlana
    Mazzuti, Laura
    Turriziani, Ombretta
    Schiavo, Oscar G.
    Toni, Danilo
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [49] Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients
    Manuela De Michele
    Giulia d’Amati
    Martina Leopizzi
    Marta Iacobucci
    Irene Berto
    Svetlana Lorenzano
    Laura Mazzuti
    Ombretta Turriziani
    Oscar G. Schiavo
    Danilo Toni
    Journal of Hematology & Oncology, 15
  • [50] Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients
    Pipolo, Carlotta
    Bottai, Daniele
    Fuccillo, Emanuela
    Aronica, Eleonora
    Bruschi, Fabio
    Bulfamante, Antonio Mario
    Castellani, Luca
    Canevini, Maria Paola
    Chiumello, Davide
    Ferrari, Sergio
    Martinelli, Carla
    Muttini, Stefano
    Priori, Alberto
    Saibene, Alberto Maria
    Spoldi, Chiara
    Tosi, Delfina
    Zanusso, Gianluigi
    Bulfamante, Gaetano Pietro
    Felisati, Giovanni
    PLOS ONE, 2022, 17 (04):